Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067756 · ClinicalTrials.gov registry record · Phase 2
4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?
A Phase 2 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT00067756 is a Phase 2 study that has completed, run by University of Florida. The registered enrollment target is 12 participants.
The verdict
NCT00067756, a Phase 2 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether 4-PBA will increase the level of AAT in persons with AAT deficiency whether or not they have liver disease.
Interventions
- DRUG 4-PBA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2001-11 |
| Est. Completion | 2003-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00067756
The ClinicalTrials.gov registry entry for NCT00067756 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 4-PBA is the first listed.
NCT00067756 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00067756 about?
NCT00067756 is a clinical study titled "4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?". The purpose of this study is to find out whether 4-PBA will increase the level of AAT in persons with AAT deficiency whether or not they have liver disease.
What is the current status of trial NCT00067756?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2001-11. Estimated completion is 2003-10.
What interventions are being tested in trial NCT00067756?
The interventions under investigation include: 4-PBA (DRUG).
Who is sponsoring clinical trial NCT00067756?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.